NL8420316A - Analgetische en ontstekingsremmende preparaten met daarin xanthinen en een werkwijze voor het toepassen daarvan. - Google Patents

Analgetische en ontstekingsremmende preparaten met daarin xanthinen en een werkwijze voor het toepassen daarvan. Download PDF

Info

Publication number
NL8420316A
NL8420316A NL8420316A NL8420316A NL8420316A NL 8420316 A NL8420316 A NL 8420316A NL 8420316 A NL8420316 A NL 8420316A NL 8420316 A NL8420316 A NL 8420316A NL 8420316 A NL8420316 A NL 8420316A
Authority
NL
Netherlands
Prior art keywords
derivative
composition
alkyl
xanthine
xanthine derivative
Prior art date
Application number
NL8420316A
Other languages
English (en)
Dutch (nl)
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of NL8420316A publication Critical patent/NL8420316A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8420316A 1983-12-12 1984-12-12 Analgetische en ontstekingsremmende preparaten met daarin xanthinen en een werkwijze voor het toepassen daarvan. NL8420316A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/560,576 US4558051A (en) 1983-10-11 1983-12-12 Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US56057683 1983-12-12
US8402035 1984-12-12
PCT/US1984/002035 WO1985002540A1 (en) 1983-12-12 1984-12-12 Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Publications (1)

Publication Number Publication Date
NL8420316A true NL8420316A (nl) 1985-11-01

Family

ID=24238396

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8420316A NL8420316A (nl) 1983-12-12 1984-12-12 Analgetische en ontstekingsremmende preparaten met daarin xanthinen en een werkwijze voor het toepassen daarvan.

Country Status (15)

Country Link
US (1) US4558051A (it)
EP (1) EP0165308B1 (it)
JP (1) JPS61500665A (it)
AT (1) AT389997B (it)
AU (1) AU574419B2 (it)
CA (1) CA1246453A (it)
CH (1) CH669730A5 (it)
DE (1) DE3490583T1 (it)
GB (1) GB2161076B (it)
IE (1) IE58158B1 (it)
IT (1) IT1177389B (it)
NL (1) NL8420316A (it)
SE (1) SE469874B (it)
WO (1) WO1985002540A1 (it)
ZA (1) ZA849675B (it)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them
CH669523A5 (it) * 1986-06-25 1989-03-31 Mepha Ag
EP0258191B1 (en) * 1986-08-28 1992-05-27 Sandoz Ag Xanthine derivatives
CH670090A5 (it) * 1986-10-27 1989-05-12 Nestle Sa
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
ES2039646T3 (es) * 1987-11-13 1993-10-01 Glaxo Group Limited Derivados de fenetanolamina.
US4883818A (en) * 1987-11-17 1989-11-28 Analgesic Associates Onset-hastened/enhanced analgesia
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
KR930701994A (ko) * 1990-09-11 1993-09-08 제이코브스 코넬리스 레이서 개선된 진통 효과를 제공하는 방법
AU5132893A (en) * 1992-09-29 1994-04-26 Mcneil-Ppc, Inc. Ibuprofen-caffeine combinations
US5340813A (en) * 1992-11-09 1994-08-23 Cell Therapeutics, Inc. Substituted aminoalkyl xanthine compounds
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6586429B2 (en) * 2000-11-29 2003-07-01 Cell Therapeutics, Inc. Tricyclic fused xanthine compounds and their uses
ES2292775T3 (es) 2001-07-06 2008-03-16 Penwest Pharmaceuticals Co. Formulaciones de liberacion prolongada de oximorfona.
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
CA2452872A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US6977300B2 (en) * 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
CN100467469C (zh) 2001-11-09 2009-03-11 Cv医药有限公司 A2b腺苷受体拮抗剂
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7317017B2 (en) 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
SI1789053T1 (sl) * 2004-09-01 2012-09-28 Gilead Sciences Inc Postopek celjenja rane z uporabo antagonistov A2B adenozinskih receptorjev
CL2007002425A1 (es) * 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
AU2016246068B2 (en) 2015-04-08 2020-08-27 Lewis And Clark Pharmaceuticals, Inc. Xanthine-substituted alkynyl carbamates/reverse carbamates as A2b antagonists
CN109912598B (zh) * 2019-03-27 2022-09-13 四川大学华西医院 防治炎症反应的核苷类衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US3936528A (en) * 1974-02-13 1976-02-03 Syntex Corporation Analgesic formulations having enhanced therapeutic activity
AU532600B2 (en) * 1977-04-02 1983-10-06 Hoechst A.G. Alkenyl xanthines and pharmaceutical compositions
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
DE3390116C2 (de) * 1982-07-22 1994-06-16 Richardson Vicks Inc Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4479956A (en) * 1983-04-26 1984-10-30 Analgeic Associates Analgesic compositions comprising propiram and methods of using same

Also Published As

Publication number Publication date
GB8519256D0 (en) 1985-09-04
SE8503762L (sv) 1985-08-09
AU3747485A (en) 1985-06-26
EP0165308A1 (en) 1985-12-27
ATA905384A (de) 1989-08-15
WO1985002540A1 (en) 1985-06-20
SE8503762D0 (sv) 1985-08-09
US4558051A (en) 1985-12-10
DE3490583T1 (de) 1986-04-03
EP0165308B1 (en) 1989-03-22
EP0165308A4 (en) 1986-05-16
IE843166L (en) 1985-06-12
IT1177389B (it) 1987-08-26
CH669730A5 (it) 1989-04-14
IT8424009A0 (it) 1984-12-12
CA1246453A (en) 1988-12-13
GB2161076A (en) 1986-01-08
JPS61500665A (ja) 1986-04-10
IT8424009A1 (it) 1986-06-12
AT389997B (de) 1990-02-26
GB2161076B (en) 1988-03-30
AU574419B2 (en) 1988-07-07
SE469874B (sv) 1993-10-04
IE58158B1 (en) 1993-07-28
ZA849675B (en) 1985-07-31

Similar Documents

Publication Publication Date Title
NL8420316A (nl) Analgetische en ontstekingsremmende preparaten met daarin xanthinen en een werkwijze voor het toepassen daarvan.
AU569935B2 (en) Analgesic & anti-inflammatory compositions containing xanthines
EP0114886B1 (en) Improved analgesic and anti-inflammatory compositions comprising caffeine
CA2450777C (en) Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia
US4464376A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4656177A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
NL8320239A (nl) Verbeterde analgetische en ontstekingsremmende preparaten met daarin ibuprofen, alsmede werkwijze voor het gebruik daarvan.
CA1217429A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4587249A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
EP2001479A2 (en) Co-administration of adenosine a1 receptor antagonists and anticonvulsants
US20050176725A1 (en) Combination of glivec (sti571) with a cyclin-dependent kinase inhibitor, especially flavopiridol, in the treatment of cancer
WO1984002273A1 (en) Analgesic combinations